GREENLAND MINES LTD Temporary Equity, Other Changes
GREENLAND MINES LTD (GRML) reported Temporary Equity, Other Changes of $102.42 million for the 12-month period ending 2023-12-31, per its 10-Q filed 2024-05-23.
Discontinued › Shareholders' Equity
us-gaap:TemporaryEquityOtherChanges · last filed 2024-05-23
- GREENLAND MINES LTD temporary equity, other changes for the quarter ending 2023-06-30 was -$1.01M.
- GREENLAND MINES LTD temporary equity, other changes for the quarter ending 2023-03-31 was -$1.32M.
- GREENLAND MINES LTD temporary equity, other changes for the quarter ending 2022-12-31 was -$2.22M.
- GREENLAND MINES LTD temporary equity, other changes for the quarter ending 2022-09-30 was -$27.17M.
- GREENLAND MINES LTD temporary equity, other changes for fiscal 2022 was -$29.39M.
| Period end | Temporary Equity, Other Changes 3 month | Temporary Equity, Other Changes 6 month | Temporary Equity, Other Changes 9 month | Temporary Equity, Other Changes 12 month |
|---|---|---|---|---|
| 2023-12-31 | $102.42M 10-Q · filed 2024-05-23 | |||
| 2023-06-30 | -$1.01M 10-Q · filed 2023-08-21 | -$2.34M 10-Q · filed 2023-08-21 | -$4.55M derived: sum of 3 quarters · filed 2023-10-18 | -$31.72M derived: sum of 4 quarters · filed 2023-10-18 |
| 2023-03-31 | -$1.32M 10-Q · filed 2023-05-24 | -$3.54M derived: sum of 2 quarters · filed 2023-10-18 | -$30.71M derived: sum of 3 quarters · filed 2023-10-18 | -$57.42M derived: sum of 4 quarters · filed 2023-10-18 |
| 2022-12-31 | -$2.22M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-10-18 | -$29.39M derived: sum of 2 quarters · filed 2023-10-18 | -$56.10M derived: sum of 3 quarters · filed 2023-10-18 | -$29.39M 10-K/A · filed 2023-10-18 |
| 2022-09-30 | -$27.17M 10-Q · filed 2022-11-14 | -$53.88M derived: sum of 2 quarters · filed 2023-08-21 | -$27.17M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -$26.71M 10-Q · filed 2023-08-21 | -$26.71M 10-Q · filed 2023-08-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |